Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-05

FDA Approved: OXCARBAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for oxcarbazepine from Sun Pharmaceutical Industries, Inc., resulting in an approved labeling change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)